medroxyprogesterone acetate has been researched along with Granulocytic Leukemia, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fink, M | 1 |
| Bavaro, P; Bellati, U; Bizzarri, M; Carabella, G; Iammarrone, E; Mattaeis, RD; Torlontano, G | 1 |
2 other study(ies) available for medroxyprogesterone acetate and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Possible effect of medroxyprogesterone acetate (MPA) in lymphoid blast crisis of chronic myelogenous leukemia.
Topics: Blast Crisis; Blood Cells; Bone Marrow; Drug Therapy, Combination; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Medroxyprogesterone Acetate; Middle Aged; Prednisone; Vincristine | 1994 |
[Efficacy of estrogen-progestin replacement therapy after bone marrow transplantation].
Topics: Acute Disease; Adolescent; Adult; Anemia, Aplastic; beta-Thalassemia; Bone Marrow Transplantation; Child; Child, Preschool; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Medroxyprogesterone Acetate; Multiple Myeloma; Neural Tube Defects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Primary Myelofibrosis; Primary Ovarian Insufficiency; Progesterone Congeners; Prospective Studies | 1996 |